Paid Clinical Trials in Camden, NJ
As of June 2026, 117 paid clinical trials are recruiting in Camden, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Camden offers studies at sites including Cooper Hospital University Medical Center for conditions such as Breast Cancer, Coronary Artery Disease, Hypertension, Acute Ischemic Stroke. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Camden
Trials by drug in Camden
Filter results
117 clinical trials
↓ Download CSVBuprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency Department
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
Pivotal Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates
Localized Injection of Lidocaine Via the Middle Meningeal Artery for Intractable Headache Treatment
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
The ArtixASCEND Study
RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients
Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Placing External Ventricular Drains Using Assistive Augmented Reality or Image-Based Localization
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Testing Gene PilotLX With Latinx Cancer Patients
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
SPYRAL GEMINI Pilot Study
Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)
The Pivotal Study of RapidPulseTM Aspiration System
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Prevail Global Study
Non-Invasive Preeclampsia Screening and Biobank
StrokeNet Thrombectomy Endovascular Platform
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Standard Versus High Dose ED-Initiated Buprenorphine Induction
Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
About research studies in Camden
Camden has approximately 117 recruiting research studies across a wide range of therapeutic areas. New Jersey hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Camden
Researchers run research studies in Camden, NJ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cooper Hospital University Medical Center | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 26 |
| Cooper University Hospital | Opioid Use, Opioid Use Disorder, Postoperative Pain | 22 |
| Cooper University Health Care | Acute Stress Reaction, Anticoagulant-induced Bleeding, Bone Metastases | 10 |
| MD Anderson Cancer Center at Cooper | Advanced Melanoma, Breast Cancer, Cancer | 8 |
| Cooper Health System | Acute Ischemic Stroke, Cryptogenic Stroke, Diabetes | 6 |
| Cooper Health | Breast Neoplasms, Carcinoma, Ductal, Breast, Communication | 5 |
| Cooper Health Center | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 3 |
| Cooper University Health | ICH - Intracerebral Hemorrhage, IVH- Intraventricular Hemorrhage, Intracranial Aneurysm | 3 |
| The Cooper Health System | Cardiac Surgery, Disorder, Down Syndrome | 3 |
| Virtua Health | Acute Myocardial Infarction (AMI), Cardiovascular Risk, Hypertension | 3 |
| Virtua Our Lady of Lourdes Hospital | Cardiovascular Diseases, Chronic Kidney Diseases, Coronary Artery Disease | 3 |
| Cooper Hospital UNIV MED CTR. | Colorectal Adenocarcinoma, Melanoma, Stage I Colorectal Cancer AJCC v8 | 2 |
| Our Lady of Lourdes | Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis | 2 |
| CUH - Sheridan Pavilion - Three Cooper Plaza | Proteinuric Kidney Disease | 1 |
| Camden, NJ Investigative | Acute Heart Failure, Heart Failure | 1 |
| Children's Regional Hospital, Cooper University Health Care | Neonatal Opioid Withdrawal Syndrome | 1 |
| Cooper Health Systems | Tricuspid Regurgitation, Tricuspid Valve Disease, Tricuspid Valve Insufficiency | 1 |
| Cooper Neurological Institute | Normal Pressure Hydrocephalus | 1 |
| Cooper University Health System | Acute Stress Disorder, Acute Stress Reaction, Neurocognitive Function | 1 |
| Cooper University Healthcare | Spasticity, Cerebral or Spinal Condition | 1 |
| Cooper University Hospital (2015-ongoing) | Cancer, Pregnancy | 1 |
| Cooper University Hospital/Cooper Medical School of Rowan University | Awareness, Intubation Complication, Mechanical Ventilation | 1 |
| MD Anderson Cancer Center at Cooper Hospital | Locally Advanced Pancreatic Cancer | 1 |
| MD Anderson Cancer Center at Cooper- Two Cooper Plaza | Breast Adenocarcinoma, Endometrial Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC) | 1 |
| MD Anderson Cooper | Metastatic Non Small Cell Lung Cancer | 1 |
Active & Upcoming Studies in Camden (2026)
Recruiting trials in Camden grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (52 active studies)
- A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression · Phase 3 · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · Natera, Inc.
Neurology & pain (9 active studies)
- Localized Injection of Lidocaine Via the Middle Meningeal Artery for Intractable Headache Treatment · Phase 2 · Daniel A Tonetti, MD
- Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i) · Temple University
Cardiovascular (9 active studies)
- SPYRAL GEMINI Pilot Study · Medtronic Vascular
- Prevail Global Study · Medtronic Vascular
Mental health & behavior (2 active studies)
- The ED-AWARENESS-2 Trial · Washington University School of Medicine
- Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome · The Cooper Health System
Diabetes & metabolic (2 active studies)
- SPYRAL GEMINI Pilot Study · Medtronic Vascular
- Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes · Endogenex, Inc.
Vaccines (1 active study)
- RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients · Phase 4 · The Cooper Health System
HIV / STI (1 active study)
- Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101 · Phase 1 · Excision BioTherapeutics
Pediatric (1 active study)
- Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome · HELP for NOWS Consortium
Common conditions studied in Camden
- Breast Cancer (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Coronary Artery Disease (3 active studies). Coronary artery disease research evaluates lipid-lowering therapies, anti-inflammatory agents, and new revascularization devices.
- Hypertension (3 active studies). Hypertension research tests new antihypertensive drug classes, renal denervation devices, and fixed-dose combinations for resistant disease.
- Acute Ischemic Stroke (2 active studies). Stroke trials test acute reperfusion strategies, neuroprotective agents, and rehabilitation technologies to improve recovery.
- Acute Myeloid Leukemia (2 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm (2 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
Leading research sponsors in Camden
- The Cooper Health System
- NRG Oncology
- National Cancer Institute (NCI)
- AstraZeneca
- M.D. Anderson Cancer Center
Local regulations and guidelines
Clinical trials in New Jersey are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Jersey research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Camden. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Camden
Hipa.ai aggregates every recruiting study in Camden from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Camden?
There are approximately 117 recruiting clinical trials in Camden, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Camden pay participants?
Most recruiting trials in Camden compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Camden?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Camden?
The most common conditions under active study in Camden include Breast Cancer (4), Coronary Artery Disease (3), Hypertension (3), Acute Ischemic Stroke (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Camden?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Camden on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Camden?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Camden?
Recruiting research sites in Camden include Cooper Hospital University Medical Center, Cooper University Hospital, Cooper University Health Care, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Camden right now?
The largest active categories in Camden are Cancer & tumors (52), Neurology & pain (9), Cardiovascular (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.